PEAK6’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.98M Sell
34,100
-25,700
-43% -$8.45M 0.02% 579
2025
Q4
$21M Buy
59,800
+15,800
+36% +$5.34M 0.04% 367
2025
Q3
$14.2M Buy
44,000
+33,800
+331% +$10.5M 0.02% 540
2025
Q2
$3.97M Sell
10,200
-4,000
-28% -$1.61M 0.01% 1077
2025
Q1
$6.18M Sell
14,200
-4,700
-25% -$1.89M 0.01% 805
2024
Q4
$6.97M Buy
+18,900
New +$7.91M 0.01% 723

Other funds holding ELV

PEAK6's ELV Position: Q1 2026 in Review

PEAK6 sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 29,773 shares — an estimated $9.79M sold.

PEAK6 first reported a position in ELV in Q4 2024 and held it in 5 quarters. The position peaked at $10.8M in Q1 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • PEAK6 reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • PEAK6 sold 29,773 Elevance Health shares in Q1 2026, an estimated $9.79M.
  • PEAK6 first reported a position in Elevance Health in Q4 2024 and held it in 5 quarters.
  • PEAK6's Elevance Health position peaked at $10.8M in Q1 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on PEAK6's 13F filing for Q1 2026, filed 14 May 2026.